Aussie doctors hail precision radiation findings on metastatic prostate cancer
It's effective for men with up to five lesions, say researchers
Precision radiation treatment can delay treatment escalation in men with metastatic prostate cancer without leading to severe toxicity, according to a landmark Australian study.
For the trial — the world’s largest and first to include patients with up to five metastatic lesions — almost 200 men were treated using stereotactic body radiation therapy, Melbourne’s Icon Cancer Centre-led researchers report in the International Journal of Cancer.
